Zomedica Pharmaceuticals Corp Cash Flow Conversion Efficiency
Zomedica Pharmaceuticals Corp cash flow conversion efficiency. Based on the latest financial reports, Zomedica Pharmaceuticals Corp (ZOM) has a cash flow conversion efficiency ratio of -0.050x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.65 Million) by net assets ($132.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zomedica Pharmaceuticals Corp (2013–2024)
Cash flow conversion efficiency of Zomedica Pharmaceuticals Corp from 2013 to 2024. This chart illustrates how Zomedica Pharmaceuticals Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Zomedica Pharmaceuticals Corp for real-time trading data and today's change.
Zomedica Pharmaceuticals Corp Cash Flow Conversion Ratio Explained
Zomedica Pharmaceuticals Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zomedica Pharmaceuticals Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zomedica Pharmaceuticals Corp ranked by their cash flow conversion efficiency. Also see market value of Zomedica Pharmaceuticals Corp for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BitNine Co. Ltd.
KQ:357880
|
-0.072x |
|
INTER RAO Lietuva AB
WAR:IRL
|
0.213x |
|
Integra Indocabinet Tbk PT
JK:WOOD
|
0.031x |
|
IL&FS Engineering and Construction Company Limited
NSE:IL&FSENGG
|
0.034x |
|
Manuka Resources Ltd
AU:MKR
|
-0.335x |
|
Kootenay Silver Inc
V:KTN
|
-0.025x |
|
Hotelim Société Anonyme
PA:MLHOT
|
N/A |
|
Covalon Technologies Ltd.
V:COV
|
0.218x |
Annual Cash Flow Conversion Efficiency for Zomedica Pharmaceuticals Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zomedica Pharmaceuticals Corp from 2013 to 2024. Review ZOM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $195.66 Million | $-23.63 Million | -0.121x | -81.45% |
| 2023-12-31 | $240.02 Million | $-15.97 Million | -0.067x | -52.50% |
| 2022-12-31 | $267.39 Million | $-11.67 Million | -0.044x | +17.18% |
| 2021-12-31 | $270.89 Million | $-14.28 Million | -0.053x | +83.43% |
| 2020-12-31 | $51.07 Million | $-16.24 Million | -0.318x | +95.74% |
| 2019-12-31 | $2.10 Million | $-15.63 Million | -7.461x | -144.76% |
| 2018-12-31 | $3.66 Million | $-11.15 Million | -3.048x | -88.54% |
| 2017-12-31 | $4.39 Million | $-7.09 Million | -1.617x | -46.52% |
| 2016-12-31 | $4.13 Million | $-4.56 Million | -1.103x | -8115.62% |
| 2015-12-31 | $3.71 Million | $-49.88K | -0.013x | +95.42% |
| 2014-12-31 | $141.41K | $-41.44K | -0.293x | +2.74% |
| 2013-12-31 | $206.38K | $-62.19K | -0.301x | -- |
About Zomedica Pharmaceuticals Corp
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital sign… Read more